We are extremely pleased to announce that we are continually the market leader in volume sales to patients of our OTC drug, Urosept.
Urosept is the No. 1 drug for Patients in Poland*, which has been available in pharmacies for 36 years. We thus complete the information obligation and publish a letter confirming the above, which we received from IQVIA a world leader in advanced analysis and expertise.
*Market leader in volume sales to patients based on IQVIA Pharmascope Poland, sellout units, YTD/06/2020, 12C1 URINARY SYSTEM CONDISTIONS, applies to Urosept TAB 60. Source: internal calculations via IQVIA database: Poland Pharmascope YTD/06/2020, Units © 2020. IQVIA and its affiliates. All rights reserved.
